================================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 1)(1)
ImmuCell Corporation
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $0.10 par value per share
--------------------------------------------------------------------------------
(Title of Class of Securities)
452525 30 6
--------------------------------------------------------------------------------
(CUSIP Number)
Jonathan E. Rothschild
111 Briney Avenue, #2509
Pompano Beach, FL 33062
(207) 878-2770
--------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
June 27, 2000
--------------------------------------------------------------------------------
(Date of Event which Requires Filing of This Statement)
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition that is the subject of this Schedule 13D, and is filing
this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the
following box [_]. Note: Schedules filed in paper format shall include a signed
original and five copies of the schedule, including all exhibits. See Rule 13d-7
for other parties to whom copies are to be sent.
----------
(1) The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page. The information required on
the remainder of this cover page shall not be deemed to be "filed" for the
purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise
subject to the liabilities of that section of the Act but shall be subject to
all other provisions of the Act (however, see the Notes).
(SC13D-07/99)
(Continued on following pages)
================================================================================
CUSIP No.452525 30 6 13D Page 2 of 7 Pages
________________________________________________________________________________
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Jonathan E. Rothschild
________________________________________________________________________________
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [_]
_______________________________________________________________________________
3 SEC USE ONLY
________________________________________________________________________________
4 SOURCE OF FUNDS
PF and AF (See Item #3)
_______________________________________________________________________________
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) [_]
________________________________________________________________________________
6 CITIZENSHIP OR PLACE OF ORGANIZATION
USA
_________________________________________________________________
7 SOLE VOTING POWER
NUMBER OF 264,100 (includes 122,100 shares owned indirectly through a
SHARES wholly owned corporation and 24,500 shares owned indirectly
through a profit sharing plan of that corporation)
_________________________________________________________________
8 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 0
_________________________________________________________________
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
264,100 (includes 122,100 shares owned indirectly through a
wholly owned corporation and 24,500 shares owned indirectly
through a profit sharing plan of that corporation)
PERSON _________________________________________________________________
WITH 10 SHARED DISPOSITIVE POWER
0
________________________________________________________________________________
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
264,100(includes 122,100 shares owned indirectly through a
wholly owned corporation and 24,500 shares owned indirectly
through a profit sharing plan of that corporation)
________________________________________________________________________________
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[_]
________________________________________________________________________________
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
9.7%
________________________________________________________________________________
14 TYPE OF REPORTING PERSON*
IN
________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No.452525 30 6 13D Page 3 of 7 Pages
________________________________________________________________________________
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Arterio, Inc.
________________________________________________________________________________
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [_]
_______________________________________________________________________________
3 SEC USE ONLY
________________________________________________________________________________
4 SOURCE OF FUNDS
WC
_______________________________________________________________________________
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) [_]
________________________________________________________________________________
6 CITIZENSHIP OR PLACE OF ORGANIZATION
California
_________________________________________________________________
7 SOLE VOTING POWER
NUMBER OF 122,100
SHARES _________________________________________________________________
8 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 0
_________________________________________________________________
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
122,100
PERSON _________________________________________________________________
WITH 10 SHARED DISPOSITIVE POWER
0
________________________________________________________________________________
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
122,100
________________________________________________________________________________
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[_]
________________________________________________________________________________
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
4.5%
________________________________________________________________________________
14 TYPE OF REPORTING PERSON*
CO
________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No.452525 30 6 13D Page 4 of 7 Pages
________________________________________________________________________________
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Arterio, Inc. Profit Sharing Plan
________________________________________________________________________________
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [_]
_______________________________________________________________________________
3 SEC USE ONLY
________________________________________________________________________________
4 SOURCE OF FUNDS
WC
_______________________________________________________________________________
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) [_]
________________________________________________________________________________
6 CITIZENSHIP OR PLACE OF ORGANIZATION
California
_________________________________________________________________
7 SOLE VOTING POWER
NUMBER OF 24,500
SHARES _________________________________________________________________
8 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 0
_________________________________________________________________
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
24,500
PERSON _________________________________________________________________
WITH 10 SHARED DISPOSITIVE POWER
0
________________________________________________________________________________
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
24,500
________________________________________________________________________________
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[_]
________________________________________________________________________________
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.9%
________________________________________________________________________________
14 TYPE OF REPORTING PERSON*
CO
________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 452525 30 6 13D Page 5 of 7 Pages
________________________________________________________________________________
Item 1. Security and Issuer.
Jonathan E. Rothschild, Arterio, Inc., a corporation wholly owned by
Mr. Rothschild, and the Arterio Inc. Profit Sharing Plan hereby amend
their report to the Securities and Exchange Commission on Schedule 13D
dated April 25, 1997 (the "Schedule 13D") in the manner set forth
below. The Schedule 13D relates to common stock, par value $0.10 per
share, of ImmuCell Corporation, a Delaware corporation.
________________________________________________________________________________
Item 2. Identity and Background.
(a) This amendment is filed on behalf of Mr. Jonathan E. Rothschild,
Arterio, Inc. and the Arterio Inc. Profit Sharing Plan
(collectively the "Reporting Parties"). See Exhibit A to the
Schedule 13D filed on behalf of Mr. Rothschild, Arterio Inc. and
the Arterio Inc. Profit Sahring Plan dated as of April 25, 1997 for
a copy of their agreement in writing to file this amendment on
behalf of each of them.
(b) Mr. Rothschild's address is 111 Briney Avenue, #2509 Pompano Beach,
FL 33062 and the address for Arterio Inc. and the Arterio Inc.
Profit sharing Plan is 1061B Shary Circle, Concord, CA 94518.
(c) Mr. Rothschild is a private investor and president and sole owner
of Arterio (1), a Sub S corporation incorporated in California.
Arterio is a vitamin and nutrition company.
(d) The Reporting Parties, and their respective officers, directors,
general partners, investment managers or trustees have not been
convicted in a criminal proceeding during the last five years
(excluding traffic violations or similar misdemeanors).
(e) The Reporting Parties, and their respective officers, directors,
general partners, investment managers or trustees have not party to
a civil proceeding of a judicial or administrative body of
competent jurisdiction, as a result of which such party was or is
subject to judgement, decree or final order enjoining future
violations of, or prohibiting or mandating activities subject to,
Federal or State securities laws or finding any violation with
respect to such laws, during the last five years.
(f) Mr. Rothschild is a citizen of the United States.
(1) Mr. Rothschild is the sole owner of Arterio Inc. and in such capacity has
full control over Arterio Inc. and the Arterio Inc. Profit Sharing Plan.
_______________________________________________________________________________
Item 3. Source and Amount of Funds or Other Consideration.
Since the filing of the Schedule 13D, Mr. Rothschild has acquired
36,500 additional shares of common stock of the Issuer in the open
market with personal funds for an aggregate purchase price of
approximately $119,000, Arterio Inc. has acquired 87,800 additional
shares in the open market using its general funds for an aggregate
purchase price of approximately $281,000 and the Arterio Inc. Profit
Sharing Plan has acquired 21,500 additional shares in the open market
using its general funds for an aggregate purchase price of
approximately $67,000.
CUSIP No. 452525 30 6 13D Page 6 of 7 Pages
________________________________________________________________________________
Item 4. Purpose of Transaction.
The Reporting Parties acquired the shares of Common Stock of the Issuer
as an investment in the Issuer. Although the Reporting Parties have not
formulated any definitive plans, they may from time to time acquire or
dispose of Common Stock of the Issuer if and when they deem it
appropriate. Except as indicated in this Schedule 13D, the Reporting
Parties currently have no plans or proposals that relate to or would
result in any to the matters described in subparagraphs (a) through (j)
of Item 4 of Schedule 13D.
Mr. Rothschild has been nominated for election to the Board of
Directors of the Issuer at the Annual Meeting of Shareholders of the
Issuer to be held on June 13, 2001. If so elected, Mr. Rothschild would
receive an automatic grant of an option to acquire 15,000 shares of the
Issuer's common stock, at the fair market value on June 13, 2001.
One-third of the options subject to the grant would vest on the date he
is first re-elected to the Board by the shareholders; an additional
5,000 options would vest on the second date that the he is next
re-elected to the Board by shareholders; and the remaining 5,000
options would vest on the third date that he is re-elected to the Board
by shareholders.
_______________________________________________________________________________
Item 5. Interest in Securities of the Issuer.
(a) As of the date of this Amendment to Schedule 13D, the Reporting
Parties beneficially the Issuer's outstanding common stock as
follows:
Mr. Rothschild 264,100 shares 9.7%
Arterio Inc. 122,100 shares 4.5%
Arterio Inc. Profit Sharing Plan 24,500 shares 0.9%
(b) Mr. Rothschild holds the power to vote and to dispose of all the
shares reported on this Schedule 13D owned by himself and each of
Arterio Inc. and Arterio Inc. Profit Sharing Plan.
(c) On June 27, 2000, the Reporting Parties acquired 400 additional
shares of the Issuer's common stock in open market transactions
bringing the aggregate holdings of the Reporting Parties at that
time to 162,700 shares (6.1%). This amount represented a change of
1% from the 5.1% holdings previously reported on Schedule 13D as of
April 25, 1997, thereby requiring this amendment. Since June 27,
2000, but not within sixty days of the filing of this Amendment to
Schedule 13D, the Reporting Parties acquired an additional 101,400
shares in open market transactions.
(d) n/a
(e) n/a
CUSIP No. 452525 30 6 13D Page 7 of 7 Pages
______________________________________________________________________________
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect
to Securities of the Issuer.
None, other than the outside director stock options to be granted to
Mr. Rothschild if he is elected by shareholders to serve as a director
at the Issuer's Annual Meeting of Shareholders on June 13, 2001.
________________________________________________________________________________
Item 7. Material to be Filed as Exhibits.
n/a
_______________________________________________________________________________
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
June 8, 2001
----------------------------------------
(Date)
/s/ Jonathan E. Rothschild
----------------------------------------
(Signature)
Jonathan E. Rothschild
----------------------------------------
(Name/Title)
/s/ Jonathan E. Rothschild
----------------------------------------
(Signature)
Jonathan E. Rothschild, President,
Arterio, Inc.
----------------------------------------
(Name/Title)
/s/ Jonathan E. Rothschild
----------------------------------------
(Signature)
Jonathan E. Rothschild, Trustee,
Arterio, Inc. Profit Sharing Plan
----------------------------------------
(Name/Title)
Attention. Intentional misstatements or omissions of fact constitute federal
criminal violations (see 18 U.S.C. 1001).